✦ LIBER ✦

Are patients with non-muscle-invasive bladder cancer a suitable population for a lung cancer screening trial?

✍ Scribed by Javier Del Rey; José Placer; Felip Vallmanya; Núria Pujol; Esther Prat; Rosa Miró; Antoni Gelabert

Book ID: 109056337
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 190 KB
Volume: 106
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2009.09081.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracranial aspergillosis in a non-immu

Intracranial aspergillosis in a non-immunocompromised patient treated for muscle-invasive bladder cancer

✍ AXEL STUART MERSEBURGER; MATHIAS OELKE; JOERG HARTMANN; ARNULF STENZL; MARKUS AN 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

A phase II trial of neoadjuvant erlotini

A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results

✍ Raj S. Pruthi; Matthew Nielsen; Samuel Heathcote; Eric M. Wallen; W. Kim Rathmel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

Two-year follow-up of the phase II marke

Two-year follow-up of the phase II marker lesion study of intravesical apaziquone for patients with non-muscle invasive bladder cancer

✍ Kees Hendricksen; Antoine G. van der Heijden; Erik B. Cornel; Henk Vergunst; The 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 286 KB

Phase II trial of a 75-mg/m2 dose of doc

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

✍ Vincent A. Miller; James R. Rigas; Prudence A. Francis; Stefan C. Grant; Katheri 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

## Background. A prior Phase I1 study of a 100-mg/m2 dose of docetaxel conducted at the Memorial Sloan-Kettering Cancer Center (New York, NY) demonstrated a 38% response rate with grade 3 or 4 neutropenia in 76% of the patients and a grade 2 or greater rash or infusionrelated reaction in 41% and 3

Chemotherapy with gemcitabine, cisplatin

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

✍ Ioannis Boukovinas; Nikolaos Androulakis; Nikolaos Kentepozidis; Aris Polyzos; P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Shenfu injection plus vinorelbine for el

Shenfu injection plus vinorelbine for elderly patients with non-small cell lung cancer in promoting the quality of life: a randomized controlled clinical trial

✍ Yan Hu; Anji Hou; Hongwei Zhang; Wei Zhou; Xiaoyan Shen; Yanli Huang; Li Zhou 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 143 KB